Compare PPSI & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPSI | IOBT |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 26.6M |
| IPO Year | 2008 | 2021 |
| Metric | PPSI | IOBT |
|---|---|---|
| Price | $3.51 | $0.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $12.00 | $2.25 |
| AVG Volume (30 Days) | 74.4K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1626.32 | 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,879,000.00 | N/A |
| Revenue This Year | $26.84 | N/A |
| Revenue Next Year | $10.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.26 | $0.14 |
| 52 Week High | $5.70 | $2.79 |
| Indicator | PPSI | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 23.53 |
| Support Level | $3.25 | N/A |
| Resistance Level | $4.05 | $0.40 |
| Average True Range (ATR) | 0.22 | 0.03 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 33.02 | 13.85 |
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.